A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood
Clinical trial NCT04619251 · COMPLETED
Trial details
- NCT number
- NCT04619251
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-13
- Primary completion
- 2021-07-30
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.